REGULATORY AND STRATEGIC ADVISOR CONSULTANCY AGREEMENTRegulatory and Strategic Advisor Consultancy Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • New York
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionTHIS Consultancy Agreement (the “Agreement”) is entered into by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Mary Pendergast (the “Advisor”), effective as of September 1, 2015 (the “Effective Date”).